首页> 外文期刊>Clinical and experimental pharmacology & physiology >beta-Adrenoceptor blocking activities of nipradilol and its optical isomers in pig coronary artery.
【24h】

beta-Adrenoceptor blocking activities of nipradilol and its optical isomers in pig coronary artery.

机译:尼帕地洛及其旋光异构体在猪冠状动脉中的β-肾上腺素受体阻断活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

1. beta-Adrenoceptor blocking activities of nipradilol, its four optical isomers (RR, RS, SR, SS) and denitro nipradilol were evaluated using pig isolated coronary arteries. 2. (-)-Isoprenaline produced concentration-dependent relaxations of the arteries, which were antagonized by nipradilol, its four optical isomers or denitro nipradilol under KCl-induced contracture. 3. The order of pA2 values for beta-adrenoceptor blocking activities was SR > nipradilol > SS > or = denitro nipradilol > RR > RS. 4. The nitroxy group in nipradilol appears to enhance its beta-adrenoceptor blocking activity, because the beta-adrenoceptor blocking activity of nipradilol was more potent than that of denitro nipradilol. 5. Isomers that have the S configuration (SR, SS) at the 2' position (having a hydroxyl group) in the aryloxypropanolamine showed more potent beta-adrenoceptor blocking activity than isomers that have the R configuration (RR, RS). 6. Isomers that have the R configuration (SR, RR) at the 3 position (having a nitroxy group) in the benzopyran ring showed more potent beta-adrenoceptor blocking activity than those with the S configuration (SS, RS). 7. It is suggested that the difference in configuration of the chemical structure of nipradilol may result in variations of binding affinity for the beta-adrenoceptor.
机译:1.使用猪分离的冠状动脉评估尼帕地洛,其四种旋光异构体(RR,RS,SR,SS)和脱硝基尼帕地洛的β-肾上腺素受体阻断活性。 2.(-)-异丙肾上腺素产生浓度依赖性的动脉松弛,在KCl诱导的挛缩作用下,尼泊地洛尔,其四种旋光异构体或去硝基尼泊地洛尔对此有拮抗作用。 3.β-肾上腺素受体阻断活性的pA2值的顺序为SR>尼帕地洛> SS>或=硝基尼帕地洛> RR> RS。 4.尼泊地洛尔中的硝氧基似乎增强了其β-肾上腺素受体阻滞活性,因为尼泊地洛尔的β-肾上腺素受体阻滞活性比脱硝基尼泊地洛尔更有效。 5.在芳氧基丙醇胺的2'位置(具有羟基)具有S构型(SR,SS)的异构体显示出比具有R构型(RR,RS)的异构体更有效的β-肾上腺素受体阻断活性。 6.在苯并吡喃环的3位具有R构型(SR,RR)(具有硝基氧基)的异构体显示出比具有S构型(SS,RS)的那些更有效的β-肾上腺素受体阻断活性。 7.建议尼普地洛的化学结构构型的差异可能导致对β-肾上腺素受体的结合亲和力的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号